Towards the introduction of the 'Immunoscore' in the classification of malignant tumours - Wikidata - awgldk - TriplyDB

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

http://www.wikidata.org/entity/Q27026489

about

The significance of tumor-associated immune response in molecular taxonomy, prognosis and therapy of colorectal cancer patients Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy Cytokine-Induced Modulation of Colorectal Cancer Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials Tumor-Induced Local and Systemic Impact on Blood Vessel Function Stage migration vs immunology: The lymph node count story in colon cancer Prognostic and Predictive Significance of Stromal Fibroblasts and Macrophages in Colon Cancer Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State Trial Watch: Adoptive cell transfer for oncological indications The Increasing Relevance of Tumour Histology in Determining Oncological Outcomes in Colorectal Cancer Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis Prognostic stratification of colorectal cancer patients: current perspectives Biomarkers for glioma immunotherapy: the next generation Acquired and intrinsic resistance in cancer immunotherapy Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation Obesity and colorectal cancer: molecular features of adipose tissue Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer From mice to humans: developments in cancer immunoediting In silico design and biological evaluation of a dual specificity kinase inhibitor targeting cell cycle progression and angiogenesis Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach Association of theHLA-G3′UTR polymorphisms with colorectal cancer in Italy: a first insight Heterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.Immune DNA signature of T-cell infiltration in breast tumor exomes.Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy An Immune Atlas of Clear Cell Renal Cell Carcinoma.Microenvironmental regulation of therapeutic response in cancer Emerging immunologic biomarkers: setting the (TNM-immune) stage.High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival.Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis.Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer.Going back to class I: MHC and immunotherapies for childhood cancer.The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies.

P2860

Q26738665-842AE0F0-0E34-4FF8-84A8-1EBF67DE6871 Q26745516-80BAAFBE-F65E-4947-BF07-4080BAC130CF Q26752374-28494A75-622E-4BBC-A80F-DD7B26CC426D Q26765115-834B5D0B-0C14-448A-8183-0AABDC86F344 Q26771958-7238F658-C7C8-4E59-AEBB-8701658D1C77 Q26775953-3989CB90-D26D-4E54-9289-0AAE2A708C3E Q26777108-4673C41C-7D96-4677-B416-B9BDDC3DFE54 Q26778332-4FA23522-FA27-4F16-A264-113D47752778 Q26780387-AFC7AADC-6C26-4E59-9701-540216F2DAFE Q26782573-C6527673-FB2B-48F4-A43C-D9DFD26BDBA1 Q26785545-245CDEB7-FA75-4543-932B-5B78D6EC637B Q26796255-6DAF14D9-2879-48AA-B2B0-9331546D0812 Q26797490-7185A91F-1712-4378-908F-4E0DD23D8477 Q26823543-3220E169-1F36-4B26-9715-74196CCF66A2 Q26825496-FD5EC8E7-9DA5-46F9-AB70-ED1822F76C74 Q26827701-95F49A66-3561-4460-80BF-B97691AD6520 Q26852716-273F45B3-CEFD-42F7-827B-5CA997E42203 Q28066460-85E4FF3E-038A-405D-BCD8-A701AF97F94F Q28069422-F8948DB2-8FD9-48B2-BCDE-3E33B62E1532 Q28075719-FA198289-2B49-4B58-A765-C99C56FC6831 Q28079556-4CDCB452-7935-4287-A381-0B4C5405CD94 Q28084216-CA084A31-6BCB-446E-8BC5-F0C56BF9DBE5 Q28088304-752A0B16-3F7C-4046-ABB9-565088DFC7C2 Q28544931-E5419C6A-8264-419D-885F-FF48C8ABBFFE Q28647615-36CDAB8C-34D0-4D2E-ABD3-D35C7D5D9F89 Q29030926-1F0CC62D-6A21-4DFE-AF9D-A91FF900FD7E Q30275647-DC85DE99-0266-4B82-910C-25A5FD20D026 Q30276874-AB4FE87A-CA22-4870-A50D-1D4E1F8ED00F Q30377226-B7A48914-6FBF-4453-9FA5-D6518B8CAAFC Q33416940-CCB6F668-981A-4149-9B1A-07D4F0644D1F Q33649707-AFA8A3FA-4719-4A86-9F44-1D371090BF89 Q33654609-2101A08A-F96B-4525-A78B-B1D98B3B500F Q33677916-24326236-4DF4-467D-93F7-8C6282473CE9 Q33742810-C079915B-DAD3-4AEC-AD77-D6F74E748696 Q34016833-6F5DC877-AE5F-469F-81E8-A4F872C77081 Q34103979-98059C6E-3F06-48C7-A70A-66BDDE97806C Q34169734-79D106B5-7F40-4B77-89B6-8CF5CDCB0E4C Q35009369-6D7D1A9C-802B-4F0B-A624-C91B170226EA Q35117552-899DC4C5-C441-49E2-B969-17BE1D2C2283 Q35226092-534163D1-003A-4D21-99A8-40ACD638A820

P2860

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

http://www.wikidata.org/entity/Q27026489

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@ast

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@en

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@nl

type

label

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@ast

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@en

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@nl

prefLabel

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@ast

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@en

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@nl

P1433

Q27026489-328F661F-51A6-425F-858B-5D82FEBE20F1

P1476

Q27026489-82477679-55AB-4501-87EB-B12D5EDEAD19

P2093

Q27026489-03424DD1-6C85-489A-AFB5-5C42FB517E50

Q27026489-3490A36B-73A8-4CD6-ADA7-1D79D7F44BF2

Q27026489-49642FC8-77B9-4416-8075-4666D1C997E0

Q27026489-4E52AC7A-F778-4E4C-A767-0D36508B5C19

Q27026489-4FED8E03-70D6-4D0F-A5F5-54E0E666947D

Q27026489-52E9CA40-472D-4EFE-A72F-165D9F3CCBA6

Q27026489-6232E365-ACEA-4EE9-A442-1E37F0EAE53E

Q27026489-62BAE967-4650-463A-9FB0-AF1DE8B149E8

Q27026489-67440922-3BDE-426A-867C-5BDDC4FE5426

Q27026489-674591EF-4B44-4023-8970-F3420CC5A143

P275

Q27026489-B7EBD278-FFE6-47A1-BD38-E36148FD266C

P2860

Q27026489-02866F09-5146-41FA-A52D-AA4DC6CDE013

Q27026489-0430B07A-23A9-40BC-BCC6-801022322264

Q27026489-0A0C2E0B-D7EA-4339-82AA-8F7B0706BBEB

Q27026489-0A181008-CD95-4292-B009-0633A48190EA

Q27026489-106BA1FC-E066-413B-9BB0-54411D9755F7

Q27026489-10D32330-33F8-4FD7-83D6-7CE865314C59

Q27026489-18787B99-1F1F-4150-B1C2-A42EA71FBA71

Q27026489-1DC0D538-4360-4FC6-8DF3-9AA044E3AC3E

Q27026489-1E743E54-3DD8-4A05-BFCF-D7E7F8C2CCA7

Q27026489-25B61B01-CE1B-409B-9B08-46D640F983D8

P304

Q27026489-E37F7C71-C6AD-4AF4-BBE8-61AB4F4C60FA

P31

Q27026489-D304AAE6-60B9-436C-A485-91E78E04AA2B

Q27026489-E62C7FCE-4A86-44E5-9F21-83FFF3AA31F4

P3181

Q27026489-333020EC-105F-4F72-878F-B184FF33738F

P356

Q27026489-01CBE956-3553-4D64-A72C-ED7678CAC728

P407

Q27026489-C55DE5E5-4322-40BC-8D25-DB83AEEE47FE

P433

Q27026489-49C08E51-05AC-40E0-935F-8E44993C2419

P478

Q27026489-33D8F7C8-159E-4A61-A382-6E10C1DD29B8

P50

Q27026489-619AFA5B-072A-4DC6-84F0-D97FC8BE7147

Q27026489-71E061C2-1DDF-4B69-A256-7FDEEF42D7CC

Q27026489-7BF7AAD8-7998-4F19-A49A-CEC186F567B8

Q27026489-A152E65D-FDB0-4DA1-8235-5F44738ED5F3

Q27026489-AD3BCAA3-0F6B-4538-A277-9EE6A9EABCC9

Q27026489-AF3D8C05-5E1F-4C7F-BB97-FC2914292178

Q27026489-C021F991-739A-4AFA-B126-B251D3330F34

Q27026489-C3ABCACD-A607-4EF1-A7B6-4EAF614FBCA3

Q27026489-C7C95E78-30E4-4454-89B9-8F5018CADFDC

Q27026489-DCEB28E9-969A-404F-BC17-62453A74E6B1

P5008

Q27026489-894C02EC-8D83-4D9F-8466-9A498D8C0CBA

P577

Q27026489-C98F1E0D-EACC-4C8E-8E41-03CD73941B88

Q27026489-ED879AFE-C6EC-4CA4-8B8E-A89AE6345E41

P5875

Q27026489-76DFAA74-5F4B-4A52-B867-7A1788E9B2D7

P698

Q27026489-FFF75914-9FC9-45EE-A8FE-54838B33BF72

P921

Q27026489-0F7EFC68-C361-48AF-BF5C-89E2DB2F543F

Q27026489-287A6899-44CF-46B2-BDE9-6CF8C01BE672

Q27026489-44777E58-84C4-462D-8EB2-8E15BB581CA8

Q27026489-AA5B24C6-BA6C-4391-801B-635B0394F178

P932

Q27026489-CE20A950-2794-4005-A11B-91C97D0E44D0

P3181

P356

P1433

The Journal of Pathology

P1476

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

@en

P2093

Alessandro Lugli

http://www.w3.org/2001/XMLSchema#string

Anne Berger

http://www.w3.org/2001/XMLSchema#string

Arndt Hartmann

http://www.w3.org/2001/XMLSchema#string

Bernard A Fox

http://www.w3.org/2001/XMLSchema#string

Bernhard Mlecnik

http://www.w3.org/2001/XMLSchema#string

Carlo Bifulco

http://www.w3.org/2001/XMLSchema#string

Christine Lagorce

http://www.w3.org/2001/XMLSchema#string

Corrado D'Arrigo

http://www.w3.org/2001/XMLSchema#string

Eva Zavadova

http://www.w3.org/2001/XMLSchema#string

Fabiana Tatangelo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

Cancer classification using the Immunoscore: a worldwide task force

Hallmarks of Cancer: The Next Generation

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

An immunologic portrait of cancer

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

P304

199-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

170890

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/PATH.4287

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

232

http://www.w3.org/2001/XMLSchema#string

P50

Bradly G. Wouters

Paolo Antonio Ascierto

Giuseppe V Masucci

P5008

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257754804

http://www.w3.org/2001/XMLSchema#string

P698

24122236

http://www.w3.org/2001/XMLSchema#string

P921

immunologic tests

tumor biomarkers

biomedical investigative technique

P932

4255306

http://www.w3.org/2001/XMLSchema#string